Article
Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Hematologic pathology - 1 Jan 1993
Guo J Q, Hirsch-Ginsberg C F, Xian Y M, Stass S A, Champlin R E, Giralt S A, McCredie K B, Campbell M L, Arlinghaus R B
Abstract excerpt
The benign phase of chronic myelogenous leukemia (CML) typically is characterized by an overproduction of myeloid cells that eventually progresses to a more acute stage termed blast crisis. This latter stage can exhibit either myeloid or lymphoid blast clones. Our recent results have demonstrated the presence of the P210 BCR-ABL protein in blood cells from benign phase CML patients (Guo et al., Cancer Research...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.